NCT04891536|UnknownDMC
Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy
CRIOAND2021
Loading search results
CRIOAND2021
Sponsor study identifier
interventional
100
1 country
2
Study Start
May 1, 2021
Actual (reported)Primary Completion
May 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The main objective of this project is to establish a shared comprehensive and systematic protocol for a multicenter prospective registry of patients undergoing salvage cryoablation of the prostate (SCAP). Our study hypothesis is that SCAP constitutes an effective and safe approach to treat local prostate cancer recurrence after brachytherapy or external beam radiation therapy (EBRT).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2021
Actual (reported)May 9, 2021
Actual (reported)May 18, 2021
Actual (reported)May 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
May 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Disease-free rate
absence of disease in follow-up biopsy AND PET/PSMA
1 year
ADT-free survival
Absence of androgen deprivation therapy need during follow-up
5 years
Rate of incontinence
1 year
Rate of sexual disfunction
1 year
Effect on urinary symptoms
1 year
Biochemical free survival
5 years
Metastasis free survival
5 years
Cryotherapy of the prostate through transperineal freeezing needles
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hospital Universitario Reina Sofía
Córdoba, Andalusia, Spain
Hospital Universitario Virgen de las Nieves
Granada, Andalusia, Spain
First Submitted
May 9, 2021
First Posted
May 18, 2021
Study Start
May 1, 2021
Actual (reported)Primary Completion
May 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy
Contact the study team to confirm eligibility.
Study Completion
May 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 18, 2021
Record last verified: 2021-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: